search
European Commission
Trends
- 1US intervenes in Musk's €120M fight with Brussels●Uncle Sam wants in on Musk's €120M fight with Brussels
The US government has moved to intervene in Elon Musk's €120 million legal dispute with the European Commission in Brussels. The case centres on EU penalties tied to Musk's business dealings in Europe, and Washington's entry escalates what was a corporate fight into a transatlantic regulatory clash. Commenters are watching closely, as the intervention could strain already tense US-EU relations over tech regulation.
- 2Irish regulator fines Google €403 million over GDPR breaches●Irish data protection watchdog fines Google €403M over GDPR breaches
Ireland's Data Protection Commission has fined Google €403 million for violations of the EU's General Data Protection Regulation. The decision by the watchdog, which acts as lead EU regulator for Google's European operations, adds to a series of major GDPR penalties against large technology companies in recent years.
- 3Greek MEP calls von der Leyen a 'racist' in EU Parliament●Pöbel-Attacke im EU-Parlament: Griechin beschimpft von der Leyen als „Rassistin“
A Greek member of the European Parliament publicly insulted European Commission President Ursula von der Leyen, calling her a 'racist' during a session at the EU Parliament in what German media describe as a mob-style outburst. The incident is drawing wide attention and fueling debate about conduct and tensions inside the assembly.
- 4Europe short a million health workers, Parliament seeks EU funding●Europe is short of a million health workers. Parliament asks Brussels for money
The European Parliament is calling on the European Commission to provide funding to address a shortage of roughly one million health workers across the EU. The appeal highlights growing strain on healthcare systems struggling with staff shortages, and pushes Brussels to commit money to training, recruitment and retention of medical personnel.
- 5EU approves first drug for cerebral adrenoleukodystrophy▼European Commission grants marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease
The European Commission has granted marketing authorization for NEZGLYAL (leriglitazone), making it the first pharmacological treatment approved for cerebral adrenoleukodystrophy, a rare and often fatal neurodegenerative disease affecting the brain. The decision offers a new option for patients who previously had no approved drug therapy, and it is being noted as a significant milestone in treatment of rare pediatric neurodegenerative conditions.
- 6Von der Leyen floats Canada's associate EU membership●Von der Leyen raises Canada’s possible associate EU membership
European Commission President Ursula von der Leyen has raised the possibility of Canada joining the European Union as an associate member, a status short of full membership that would deepen ties in areas such as trade and research. The suggestion marks an unusual overture toward a non-European country and has prompted discussion about how far the EU might extend its partnerships beyond the continent.